August 2, 2010
A new study of U.S. blood donors shows a "strikingly lower prevalence" of hepatitis C virus (HCV) compared with 1992-93, according to lead researcher Dr. Edward Murphy of the University of California-San Francisco.
HCV is a blood-borne infection that is primarily contracted from dirty syringes, but a small number of cases are sexually transmitted or passed from mother to infant during childbirth. The body can clear hepatitis C, though infections become chronic 75 percent to 85 percent of the time. CDC estimates that 1 percent to 5 percent of people with chronic HCV eventually die of cirrhosis or liver cancer.
In the early 1990s, about a half a percent of blood donors were positive for HCV antibodies, indicating either a chronic infection or past infection that cleared. From 2006 to 2007, the study analyzed samples from nearly 960,000 blood donors at six U.S. blood banks, finding less than a tenth of a percent were positive for HCV antibodies.
Adapted from:
Chicago Tribune
07.26.2010; Amy Norton, Reuters
This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. Visit the CDC's website to find out more about their activities, publications and services.
|
No comments have been made.
|